Risk of Dislocation After Total Hip Arthroplasty in Patients with Crowe Type IV Developmental Dysplasia of the Hip

被引:27
|
作者
Ding, Zi-chuan [1 ]
Zeng, Wei-nan [1 ]
Mou, Ping [1 ]
Liang, Zhi-min [2 ]
Wang, Duan [1 ]
Zhou, Zong-ke [1 ]
机构
[1] Sichuan Univ, West China Sch Med, West China Hosp, Dept Orthpaed, 37 Wuhou Guoxue Rd, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Sch Med, West China Hosp, Clin Res Management Dept, Chengdu, Peoples R China
关键词
Developmental dysplasia of the hip; Postoperative dislocation; Total hip arthroplasty; CONGENITAL DISLOCATION; FOLLOW-UP; OSTEOTOMY; REPLACEMENT; SUBTYPES; LENGTH; OFFSET;
D O I
10.1111/os.12665
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Objective To investigate whether the risk of dislocation after total hip arthroplasty (THA) in patients with Crowe type IV developmental dysplasia of the hip (DDH) is high and to further identify the risk factors for postoperative dislocation in these patients. Methods This retrospective cohort study reviewed Crowe type IV DDH patients undergoing THA between January 2009 and December 2017 in our institution. Each Crowe type IV DDH patient was matched with three Crowe type I, II, or III DDH patients according to gender, side and date of operation. The primary outcome of this study was postoperative dislocation after THA. Occurrence, rate, classification, treatment and outcome of dislocation were documented in detail for all patients. The dislocation rates were compared between Crowe type IV DDH patients and Crowe type I, II, or III DDH patients. Demographic data, implant factors, and surgical factors were compared between the dislocation and no dislocation groups. Multiple logistic regression analysis was used to determine the independent risk factors for dislocation in Crowe type IV hips. Results A total of 131 Crowe type IV hips were followed up for a mean of 76.5 +/- 28.1 months. Three hundred and ninety-three Crowe type I, II and III hips, including 261 type I hips, 94 type II hips, and 38 type III hips, were identified as controls and followed up for a mean of 76.4 +/- 28.2 months. No significant difference was observed in follow-up time between two groups (P = 0.804). One or more dislocations occurred in 22 of the 524 dysplasia hips (4.20%). Of the 22 dislocated hips, 20 hips (90.9%) were successfully managed with non-operative treatment. Two patients (9.1%, one Crowe type I and one Crowe type IV) experienced recurrent dislocation and required revision surgery. Crowe type IV hips had a significantly higher postoperative dislocation rate than type I, II, and III hips (11.45% vs 1.78%, P < 0.001). The use of a 22-mm femoral head (odds ratio [OR] = 23.55, 95% confidence interval [CI] = 1.901-291.788, P = 0.014), older age (OR = 1.128, 95% CI = 1.037-1.275, P = 0.031), and absence of false acetabulum (OR = 12.425, 95% CI = 1.982-77.879, P = 0.007) were identified as independent risk factors for dislocation in Crowe type IV hips. Conclusions Crowe type IV DDH patients were at a high risk of dislocation after THA, and using large femoral heads and improving abductor muscle strength may help decrease the rate of postoperative dislocation in such patients.
引用
收藏
页码:589 / 600
页数:12
相关论文
共 50 条
  • [41] Total hip arthroplasty for Crowe type IV developmental hip dysplasia - A long-term follow-up study
    Kerboull, M
    Hamadouche, M
    Kerboull, L
    [J]. JOURNAL OF ARTHROPLASTY, 2001, 16 (08): : 170 - 176
  • [42] Mid-term results of total hip arthroplasty with modified trochanteric osteotomy in Crowe type IV developmental dysplasia of the hip
    Jin, Jing-Yao
    Yoon, Taek-Rim
    Park, Kyung-Soon
    Jin, Sheng-Yu
    Jung, Dong-Min
    Li, Qing-Song
    [J]. BMC SURGERY, 2021, 21 (01)
  • [43] Leg Length Change in Total Hip Arthroplasty With Subtrochanteric Femoral Shortening Osteotomy for Crowe Type IV Developmental Hip Dysplasia
    Fujishiro, Takaaki
    Nishiyama, Takayuki
    Hayashi, Shinya
    Kurosaka, Masahiro
    Kanno, Taiki
    Masuda, Takeshi
    [J]. JOURNAL OF ARTHROPLASTY, 2012, 27 (06): : 1019 - 1022
  • [44] Total hip arthroplasty for Crowe type IV developmental dysplasia of the hip combined with intertrochanteric fracture: a case report and literature review
    Wei Chen
    Yong Ma
    Hui Ma
    Mao Nie
    [J]. BMC Surgery, 20
  • [45] Total hip arthroplasty for Crowe type IV developmental dysplasia of the hip combined with intertrochanteric fracture: a case report and literature review
    Chen, Wei
    Ma, Yong
    Ma, Hui
    Nie, Mao
    [J]. BMC SURGERY, 2020, 20 (01)
  • [46] Evaluation of Dislocation Risk Factors With Total Hip Arthroplasty in Developmental Hip Dysplasia Patients: A Multivariate Analysis
    Yetkin, Cem
    Yildirim, Timur
    Alpay, Yakup
    Tas, Suleyman K.
    Buyukkuscu, Mehmet O.
    Dirvar, Ferdi
    [J]. JOURNAL OF ARTHROPLASTY, 2021, 36 (02): : 636 - 640
  • [47] Total cementless unconstrained hip arthroplasty in Crowe type IV hip dysplasia with subtrochentric derotation osteotomy
    Ibrahim, Fady Michael Fahmy
    Gameel, Saleh
    [J]. ACTA ORTHOPAEDICA BELGICA, 2022, 88 (03): : 517 - 524
  • [48] The use of Mako robot-assisted total hip arthroplasty in the treatment of Crowe IV developmental dysplasia of the hip
    Zhu, Yun-sen
    Mo, Ting-ting
    Zhang, Jiang-nan
    Jiang, Chang
    [J]. ASIAN JOURNAL OF SURGERY, 2022, 45 (06) : 1333 - 1335
  • [49] Innovative Hip Distraction Approaches for Total Hip Arthroplasty in Crowe IV Developmental Dysplasia or Similar High-Riding Patients
    Hameed, Daniel
    Dubin, Jeremy A.
    Bains, Sandeep S.
    Moore, Mallory C.
    Standard, Shawn C.
    Mont, Michael A.
    [J]. JOURNAL OF ARTHROPLASTY, 2024, 39 (09): : S124 - S130
  • [50] Changes in Hip, Knee, and Ankle Coronal Alignments After Total Hip Arthroplasty With Transverse Femoral Shortening Osteotomy for Unilateral Crowe Type IV Developmental Dysplasia of the Hip
    Kocabiyik, Ahmet
    Misir, Abdulhamit
    Kizkapan, Turan B.
    Yildiz, Kadir I.
    Kaygusuz, Mehmet A.
    Alpay, Yakup
    Ezici, Atakan
    [J]. JOURNAL OF ARTHROPLASTY, 2017, 32 (11): : 3449 - 3456